Merck KGaA

News

Merck and Pfizer's Bavencio approved for renal cell carcinom...

Merck KGaA and Pfizer’s immunotherapy Bavencio (avelumab) has been approved by the FDA in combination with Pfizer’s Inlyta (axitinib) for the first-line treatment of

News

German Merck shows new data backing BTK drug evobrutinib in ...

Germany’s Merck KGaA has announced new mid-stage data that it says support further studies into its BTK inhibitor drug evobrutinib in multiple sclerosis, which could provide patients with a

News

Merck KGaA signs another AI deal

Merck KGaA is doubling down on AI through a new collaboration agreement with tech firm Iktos, using its generative modelling technology to speed up the discovery and design of promising new

News

Merck KGaA admits to 'challenging' 2018, as currencies hit s...

Germany’s Merck KGaA has described 2018 as a “challenging” year, which saw profits hit by currency headwinds and the company struggling to convince shareholders at semiconductor Versum firm

News

GSK bolts-on immuno-oncology candidate with €3.7bn Merck dea...

GlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an immuno-oncology drug that made a splash at last year’s ESMO meeting.

News